|
Market Closed -
Nasdaq
01:30:00 09/10/2026 am IST
|
After hours 03:34:50 am | |||
| 147.10 USD | +0.17% |
|
144.48 | -1.78% |
| 08/10 | RBC Lifts Price Target on Gilead Sciences to $126 From $123, Keeps Sector Perform Rating | MT |
| 07/10 | Pharmaceutical Group Sues US Government Over Medicare Drug Pricing Rule | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Other Pharmaceuticals | +0.17% | -1.31% | +19.85% | +25.96% | +115.88% | 18TCr |  |  | |
- Stock Market
- Stocks
- GILD Stock
- Charts Gilead Sciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
